Our findings hopefully provide a useful framework for future studies aimed at determining the relative contribution of centrosomal deficits to the various cellular alterations described to be relevant in the context of PD pathogenesis and amenable to LRRK2 kinase inhibitor-mediated strategies. Here, LRRK2 is linked to Parkinson disease.